LEP and breast cancer: To explore the signaling pathways involved in leptin-induced breast cancer cells EMT, canonical signaling pathways inhibitors, PD98059, AG490 and LY294002 were used to pretreat serum-starved MCF-7 and SK-BR-3 cells for 1 h, and then treated by 200 ng/mL leptin for 24 h.